Wealthfront Advisers LLC - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 281 filers reported holding ROYALTY PHARMA PLC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.6%.

Quarter-by-quarter ownership
Wealthfront Advisers LLC ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$2,058,216
+47.6%
75,837
+67.2%
0.01%
+50.0%
Q2 2023$1,393,998
-26.6%
45,348
-14.0%
0.01%
-33.3%
Q1 2023$1,899,177
+12.7%
52,711
+23.7%
0.01%
+12.5%
Q4 2022$1,684,698
+329.8%
42,629
+337.0%
0.01%
+300.0%
Q3 2022$392,000
+29.8%
9,754
+36.0%
0.00%0.0%
Q2 2022$302,0007,1740.00%
Other shareholders
ROYALTY PHARMA PLC shareholders Q2 2022
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$92,052,20447.04%
Indie Asset Partners, LLC 433,000$11,751,62011.84%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,095,745$111,158,5196.01%
Advanced Portfolio Management, LLC 230,000$6,242,2005.25%
Compound Global Advisors, LLC 626,412$17,000,8223.73%
Geo Capital Gestora de Recursos Ltd 135,079$3,6663.39%
TORRAY INVESTMENT PARTNERS LLC 412,633$11,198,8601.98%
Overbrook Management Corp 298,712$8,107,0441.89%
Silicon Valley Community Foundation 358,270$9,723,4481.18%
Greytown Advisors Inc. 74,601$2,024,6711.12%
View complete list of ROYALTY PHARMA PLC shareholders